SARS-CoV-2 Vaccination Safety in Guillain-Barré Syndrome, Chronic Inflammatory Demyelinating Polyneuropathy, and Multifocal Motor Neuropathy

Autor: Adája E. Baars, Krista Kuitwaard, Laura C. de Koning, Linda W.G. Luijten, W. Maaike Kok, Filip Eftimov, Luuk Wieske, H. Stephan Goedee, W. Ludo van der Pol, Patricia H. Blomkwist-Markens, Anja M.C. Horemans, Bart C. Jacobs, Pieter A. van Doorn

Publikováno v: Neurology, 100(2), e182-e191. Lippincott Williams & Wilkins
Neurology, 100(2), E182-E191. Lippincott Williams and Wilkins

Background and ObjectivesThere are concerns on the safety of SARS-CoV-2 vaccination in patients with a history of Guillain-Barré syndrome (GBS), chronic inflammatory demyelinating polyneuropathy (CIDP), and multifocal motor neuropathy (MMN). The aim

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::85b703b8aa67de6572fb6a048d2dab71
https://pure.eur.nl/en/publications/f8598d7a-88ba-49ad-9020-9a4940d423dc

Second intravenous immunoglobulin dose in patients with Guillain-Barré syndrome with poor prognosis (SID-GBS): a double-blind, randomised, placebo-controlled trial

Autor: Christa Walgaard, Bart C Jacobs, Hester F Lingsma, Ewout W Steyerberg, Bianca van den Berg, Alexandra Y Doets, Sonja E Leonhard, Christine Verboon, Ruth Huizinga, Judith Drenthen, Samuel Arends, Ilona Kleine Budde, Ruud P Kleyweg, Krista Kuitwaard, Marjon F G van der Meulen, Johnny P A Samijn, Frederique H Vermeij, Jan B M Kuks, Gert W van Dijk, Paul W Wirtz, Filip Eftimov, Anneke J van der Kooi, Marcel P J Garssen, Cees J Gijsbers, Maarten C de Rijk, Leo H Visser, Roderik J Blom, Wim H J P Linssen, Elly L van der Kooi, Jan J G M Verschuuren, Rinske van Koningsveld, Rita J G Dieks, H Job Gilhuis, Korné Jellema, Taco C van der Ree, Henriette M E Bienfait, Catharina G Faber, Harry Lovenich, Baziel G M van Engelen, Rutger J Groen, Ingemar S J Merkies, Bob W van Oosten, W Ludo van der Pol, Willem D M van der Meulen, Umesh A Badrising, Martijn Stevens, Albert-Jan J Breukelman, Casper P Zwetsloot, Maaike M van der Graaff, Marielle Wohlgemuth, Richard A C Hughes, David R Cornblath, Pieter A van Doorn, Bart C. Jacobs, Hester F. Lingsma, Ewout W. Steyerberg, Bianca Van den Berg, Alexandra Y. Doets, Sonja E. Leonhard, Ruud P. Kleyweg, Marjon F.G. Van der Meulen, Johnny P.A. Samijn, Frederique H. Vermeij, Jan B.M. Kuks, Gert W. Van Dijk, Paul W. Wirtz, Anneke J. Van der Kooi, Marcel P.J. Garssen, Cees J. Gijsbers, Maarten C. De Rijk, Leo H. Visser, Roderik J. Blom, Wim H.J.P. Linssen, Elly L. Van der Kooi, Jan J.G.M. Verschuuren, Rinske Van Koningsveld, Rita J.G. Dieks, H. Job Gilhuis, Taco C. Van der Ree, Henriette M.E. Bienfait, Karin G. Faber, Baziel G.M. Van Engelen, Rutger J. Groen, Ingemar S.J. Merkies, Bob W. Van Oosten, W. Ludo Van der Pol, Willem D.M. Van der Meulen, Umesh A. Badrising, Albert-Jan J. Breukelman, Casper P. Zwetsloot, Maaike M. Van der Graaff, Richard A.C. Hughes, David R. Cornblath, Pieter A. Van Doorn, R.B. Althingh van Geusau, C.J.M. Van Boheemen, I.M. Bronner, B. Feenstra, C. Fokke, T.A. Hoogendoorn, R. Van Houten, A. Hovestad, P.J.H.W. Jansen, E. Keuter, J. Krudde, F.H.H. Linn, J. Lion, S.M. Manschot, S.J. Mellema, D.S.M. Molenaar, D.J. Nieuwkamp, D.G. Oenema, J.C.H. Van Oostrom, N.P. Van Orshoven, R.J.O. Van der Ploeg, S. Polman, A. Ruitenberg, L. Ruts, A.J.G.M. Schyns-Soeterboek, R. Trip

Publikováno v: The Lancet Neurology, 20(4), 275-283. Lancet Publishing Group
Walgaard, C, Jacobs, B C, Lingsma, H F, Steyerberg, E W, van den Berg, B, Doets, A Y, Leonhard, S E, Verboon, C, Huizinga, R, Drenthen, J, Arends, S, Budde, I K, Kleyweg, R P, Kuitwaard, K, van der Meulen, M F G, Samijn, J P A, Vermeij, F H, Kuks, J B M, van Dijk, G W, Wirtz, P W, Eftimov, F, van der Kooi, A J, Garssen, M P J, Gijsbers, C J, de Rijk, M C, Visser, L H, Blom, R J, Linssen, W H J P, van der Kooi, E L, Verschuuren, J J G M, van Koningsveld, R, Dieks, R J G, Gilhuis, H J, Jellema, K, van der Ree, T C, Bienfait, H M E, Faber, C G, Lovenich, H, van Engelen, B G M, Groen, R J, Merkies, I S J, van Oosten, B W, van der Pol, W L, van der Meulen, W D M, Badrising, U A, Stevens, M, Breukelman, A-J J, Zwetsloot, C P, van der Graaff, M M, Wohlgemuth, M, Hughes, R A C, Cornblath, D R, van Doorn, P A, Jacobs, B C, Lingsma, H F, Steyerberg, E W, Doets, A Y, Leonhard, S E, Kleine Budde, I, Kleyweg, R P, van der Meulen, M F G, Samijn, J P A, Vermeij, F H, Kuks, J B M, van Dijk, G W, Wirtz, P W, van der Kooi, A J, Garssen, M P J, Gijsbers, C J, de Rijk, M C, Visser, L H, Blom, R J, Linssen, W H J P, van der Kooi, E L, Verschuuren, J J G M, Dieks, R J G, Gilhuis, H J, van der Ree, T C, Bienfait, H M E, Faber, K G, van Engelen, B G M, Groen, R J, Merkies, I S J, van Oosten, B W, van der Pol, W L, van der Meulen, W D M, Badrising, U A, Breukelman, A-J J, Zwetsloot, C P, van der Graaff, M M, Hughes, R A C, Cornblath, D R, van Doorn, P A, Althingh van Geusau, R B, van Boheemen, C J M, Bronner, I M, Feenstra, B, Fokke, C, Hoogendoorn, T A, van Houten, R, Hovestad, A, Jansen, P J H W, Keuter, E, Krudde, J, Linn, F H H, Lion, J, Manschot, S M, Mellema, S J, Molenaar, D S M, Nieuwkamp, D J, Oenema, D G, van Oostrom, J C H, van Orshoven, N P, van der Ploeg, R J O, Polman, S, Ruitenberg, A, Ruts, L, Schyns-Soeterboek, A J G M, Trip, R & Dutch GBS Study Group 2021, ' Second intravenous immunoglobulin dose in patients with Guillain-Barré syndrome with poor prognosis (SID-GBS): a double-blind, randomised, placebo-controlled trial ', The Lancet Neurology, vol. 20, no. 4, pp. 275-283 . https://doi.org/10.1016/S1474-4422(20)30494-4
The Lancet Neurology, 20(4), 275-283. ELSEVIER SCIENCE INC
Lancet Neurology, 20(4), 275-283. ELSEVIER SCIENCE INC
Lancet Neurology, 20(4), 275-283. Elsevier Science
Lancet Neurology, 20, 275-283
Lancet neurology, 20(4), 275-283. Lancet Publishing Group
Lancet Neurology, 20, 4, pp. 275-283

Summary Background Treatment with one standard dose (2 g/kg) of intravenous immunoglobulin is insufficient in a proportion of patients with severe Guillain-Barre syndrome. Worldwide, around 25% of patients severely affected with the syndrome are give

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fac234079bfe0a75e9f04cbd3f24fe28
https://research.vumc.nl/en/publications/ed0fb2cb-ebfd-4d51-a9f8-133541aa7cfa

Randomized trial of intravenous immunoglobulin maintenance treatment regimens in chronic inflammatory demyelinating polyradiculoneuropathy

Autor: Daan Nieboer, Ingemar S. J. Merkies, Hester F. Lingsma, Filip Eftimov, P.A. van Doorn, Bart C. Jacobs, Krista Kuitwaard, Esther Brusse, Nicolette C. Notermans, A. F. J. E. Vrancken, A. J. van der Kooi, Willem-Jan R. Fokkink

Publikováno v: European Journal of Neurology, 28(1), 286-296. Wiley-Blackwell Publishing Ltd
European journal of neurology, 28(1), 286-296. Wiley-Blackwell
European Journal of Neurology
European Journal of Neurology, 28(1), 286-296. Wiley

More frequent lower dosing does not further improve the efficacy of intravenous immunoglobulin (IVIg) in stable IVIg‐dependent chronic inflammatory demyelinating polyradiculoneuropathy. More frequent lower dosing does lead to more stable serum immu

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::392529bd96d4ec5c60048d3550a88e8e
https://pure.eur.nl/en/publications/3c2df758-444b-4fd5-b6af-5639f67cec25

Association of Albumin Levels With Outcome in Intravenous Immunoglobulin-Treated Guillain-Barre Syndrome

Autor: Pieter A. van Doorn, Krista Kuitwaard, Bart C. Jacobs, Christa Walgaard, Anne P. Tio-Gillen, Willem-Jan R. Fokkink

Publikováno v: JAMA Neurology, 74(2), 189-196. American Medical Association

Importance There is an urgent need for biomarkers to monitor treatment efficacy and anticipate outcome in patients with Guillain-Barre syndrome (GBS). Objective To assess whether there is an association between serum albumin levels, a widely used and

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::09a0de8fe0e346fa73597d174ee956b5
https://pure.eur.nl/en/publications/10d25cce-67a5-4d33-9594-38071f0431fd

Protocol of a dose response trial of IV immunoglobulin in chronic inflammatory demyelinating polyradiculoneuropathy (DRIP study)

Autor: Krista, Kuitwaard, Willem-Jan R, Fokkink, Esther, Brusse, Alexander F J E, Vrancken, Filip, Eftimov, Nicolette C, Notermans, Anneke J, van der Kooi, Ingemar S J, Merkies, Bart C, Jacobs, Pieter A, van Doorn

Publikováno v: Journal of the peripheral nervous system : JPNS. 23(1)

High peak levels of serum IgG may not be needed for maintenance treatment of chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) with intravenous immunoglobulin (IVIg). More frequent dosing of IVIg leads to more stable IgG levels and hig

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::275beb17c842f77f3d0018303e289cce
https://pubmed.ncbi.nlm.nih.gov/29119642